Cancer Neuroscience of Kinase Inhibitors: On-Target Effects on the Nervous System

Thị Lam Thái1, Sun-Young Han1

  • 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, 52828 Jinju-si, Gyeongsangnam-do, Republic of Korea.

Insights

Kinase inhibitors used in cancer therapy can impact the nervous system, affecting functions like pain and appetite. Understanding these cancer neuroscience interactions is key to improving treatments.

Area of Science:

  • Cancer neuroscience
  • Neuro-oncology
  • Pharmacology

Background:

  • Cancer neuroscience investigates the complex relationship between tumors and the nervous system.
  • Kinase inhibitors are crucial anticancer drugs with known antitumor effects.

Purpose of the Study:

  • To review the neurobiological and pharmacological effects of kinase inhibitors.
  • To explore how these drugs modulate neural function.
  • To highlight the mechanistic intersections between oncogenic and neural signaling.

Main Methods:

  • Review of literature on kinase inhibitors targeting Trk, RET, VEGF/VEGFR, EGFR, and ALK pathways.
  • Analysis of molecular mechanisms underlying drug effects on neural function.
  • Examination of examples like TrkA-mediated pain and GDF15/RET-mediated appetite regulation.

Main Results:

  • Certain kinase inhibitors possess significant antitumor activity.
  • These inhibitors can modulate neural functions, including pain perception and appetite regulation.
  • Specific pathways like TrkA and RET signaling are implicated in these neurobiological effects.

Conclusions:

  • Kinase inhibitors can have unintended but significant effects on the nervous system.
  • Understanding these off-target effects is crucial for cancer therapy.
  • Elucidating tumor-nerve crosstalk through oncogenic and neural signaling advances cancer neuroscience.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...